Scholarlink

<p>Clozapine is currently the only licensed medication for treatment-resistant schizophrenia (TRS). Ethnic inequalities in treatment with clozapine have been described extensively, particularly regarding the effect on Black ethnic groups. Here we explore the reasons for clozapine underuse in this population, identifying potential misconceptions and providing suggestions to address these barriers.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The paradox of clozapine in Black people with treatment-resistant schizophrenia

  • 期刊论文

  • 发表日期：

    2025年4月8日

查看全文
  • Eromona Whiskey,
  • Christian Bachmann,
  • Olubanke Dzahini,
  • David Taylor,
  • Ebenezer Oloyede

摘要

Clozapine is currently the only licensed medication for treatment-resistant schizophrenia (TRS). Ethnic inequalities in treatment with clozapine have been described extensively, particularly regarding the effect on Black ethnic groups. Here we explore the reasons for clozapine underuse in this population, identifying potential misconceptions and providing suggestions to address these barriers.